Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2004-01-22 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CIRES-LES-MELLO (60660), Oise
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE CIRES LES MELLO : revenue, balance sheet and financial ratios
PHARMACIE DE CIRES LES MELLO is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CIRES-LES-MELLO (60660),
this company of category PME
shows in 2025 a net income positive of 25 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE CIRES LES MELLO (SIREN 451788269)
Indicator
2025
2024
2023
2022
2021
2020
2019
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
24 978 €
37 801 €
29 977 €
95 650 €
110 551 €
100 430 €
81 339 €
57 396 €
30 089 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE CIRES LES MELLO generates positive net income of 25 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 30 k€ -> 25 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
24 978 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 51%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
51.108%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
52.209%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE CIRES LES MELLO
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2019
2020
2021
2022
2023
2024
2025
Debt ratio
85.556
80.245
83.604
80.506
73.442
81.415
91.294
69.084
51.108
Financial autonomy
47.566
48.876
49.259
50.102
52.221
49.438
44.219
48.816
52.209
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
51.112025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-6 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE CIRES LES MELLO (51.11) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
52.21%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average
In 2025, the financial autonomy of PHARMACIE DE CIRES LES MELLO (52.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 113.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
113.36
Liquidity indicators evolution PHARMACIE DE CIRES LES MELLO
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
90.572
164.916
202.815
226.227
245.961
240.04
164.247
141.645
113.36
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
113.362025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch-16 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE CIRES LES MELLO (113.36) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE DE CIRES LES MELLO in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE CIRES LES MELLO is estimated at
396 778 €
(range 269 255€ - 622 600€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
269k€396k€622k€
396 778 €Range: 269 255€ - 622 600€
NAF 5 année 2025
Valuation method used
Net Income Multiple
24 978 €
×
15.9x
=396 778 €
Range: 269 256€ - 622 600€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE CIRES LES MELLO with other companies in the same sector:
Frequently asked questions about PHARMACIE DE CIRES LES MELLO
What is the revenue of PHARMACIE DE CIRES LES MELLO ?
The revenue of PHARMACIE DE CIRES LES MELLO is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE CIRES LES MELLO profitable?
Yes, PHARMACIE DE CIRES LES MELLO generated a net profit of 25 k€ in 2025.
Where is the headquarters of PHARMACIE DE CIRES LES MELLO ?
The headquarters of PHARMACIE DE CIRES LES MELLO is located in CIRES-LES-MELLO (60660), in the department Oise.
Where to find the tax return of PHARMACIE DE CIRES LES MELLO ?
The tax return of PHARMACIE DE CIRES LES MELLO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE CIRES LES MELLO operate?
PHARMACIE DE CIRES LES MELLO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart